Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Zhang

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Spine|March 5, 2024
Predictors for Failure to Respond to Erector Spinae Plane Block Following Minimally Invasive Transforaminal Lumbar Interbody FusionEric Mai, Joshua Zhang, Amy Z Lu, et al.
Clinical Spine Surgery|February 19, 2026
Impact of Preoperative PROMIS PF on Outcomes Following Cervical Disc ReplacementCole T Kwas, Tejas Subramanian, Joshua Zhang, et al.
Clinical Breast Cancer|August 24, 2017
RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast CancerJosé Baselga, Claudio Zamagni, Patricia Gómez, et al.
Spine|September 20, 2023
Recovery Kinetics After Cervical Spine SurgeryTejas Subramanian, Daniel J Shinn, Maximilian K Korsun, et al.
Spine|March 14, 2025
Impact of Single-Level Minimally Invasive Versus Open L4-L5 and L5-S1 Transforaminal Lumbar Interbody Fusion on Postoperative Distal and Lumbar LordosisTakashi Hirase, Avani S Vaishnav, Joshua Zhang, et al.
Spine|October 31, 2024
Early NRS Leg and Back Thresholds Predict Clinical Recovery After MIS Transforaminal Lumbar Interbody Fusion for Degenerative Spine DiseaseKevin J DiSilvestro, Annika Bay, Cole T Kwas, et al.
Cancer|January 29, 2019
A phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanomaPatrick A Ott, Anna C Pavlick, Douglas B Johnson, et al.
Cancer|November 16, 2021
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920Hamid Emamekhoo, Mark R Olsen, Bradley C Carthon, et al.
The Journal of the American Academy of Orthopaedic Surgeons|October 15, 2025
Evaluating the Effect of Preoperative Symptom Duration on Patient-Reported Outcomes Following Anterior Lumber Interbody FusionEric Mai, Patawut Bovonratwet, Eric R Zhao, et al.
Spine|April 29, 2024
Impact of Preoperative Symptom Duration on Patient-Reported Outcomes Following Cervical Disc Replacement for Cervical RadiculopathyEric Mai, Eric T Kim, Austin Kaidi, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Spine|March 5, 2024
Predictors for Failure to Respond to Erector Spinae Plane Block Following Minimally Invasive Transforaminal Lumbar Interbody FusionEric Mai, Joshua Zhang, Amy Z Lu, et al.
Clinical Spine Surgery|February 19, 2026
Impact of Preoperative PROMIS PF on Outcomes Following Cervical Disc ReplacementCole T Kwas, Tejas Subramanian, Joshua Zhang, et al.
Clinical Breast Cancer|August 24, 2017
RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast CancerJosé Baselga, Claudio Zamagni, Patricia Gómez, et al.
Spine|September 20, 2023
Recovery Kinetics After Cervical Spine SurgeryTejas Subramanian, Daniel J Shinn, Maximilian K Korsun, et al.
Spine|March 14, 2025
Impact of Single-Level Minimally Invasive Versus Open L4-L5 and L5-S1 Transforaminal Lumbar Interbody Fusion on Postoperative Distal and Lumbar LordosisTakashi Hirase, Avani S Vaishnav, Joshua Zhang, et al.
Spine|October 31, 2024
Early NRS Leg and Back Thresholds Predict Clinical Recovery After MIS Transforaminal Lumbar Interbody Fusion for Degenerative Spine DiseaseKevin J DiSilvestro, Annika Bay, Cole T Kwas, et al.
Cancer|January 29, 2019
A phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanomaPatrick A Ott, Anna C Pavlick, Douglas B Johnson, et al.
Cancer|November 16, 2021
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920Hamid Emamekhoo, Mark R Olsen, Bradley C Carthon, et al.
The Journal of the American Academy of Orthopaedic Surgeons|October 15, 2025
Evaluating the Effect of Preoperative Symptom Duration on Patient-Reported Outcomes Following Anterior Lumber Interbody FusionEric Mai, Patawut Bovonratwet, Eric R Zhao, et al.
Spine|April 29, 2024
Impact of Preoperative Symptom Duration on Patient-Reported Outcomes Following Cervical Disc Replacement for Cervical RadiculopathyEric Mai, Eric T Kim, Austin Kaidi, et al.
Pageof 8